Pharmacogenetics of pain management in Zimbabwean patients with sickle cell disease

dc.contributor.author	Mapira, Nyasha Lorraine
dc.contributor.author	Thelingwani, Roslyn Stella
dc.contributor.author	Chikwambi, Zedias
dc.contributor.author	Kuona, Patience
dc.contributor.author	Masimirembwa, Collen
dc.date.accessioned	2024-12-03T07:19:21Z
dc.date.available	2024-12-03T07:19:21Z
dc.date.issued	2023-05-31
dc.identifier.citation	Mapira, N. L., Thelingwani, R. S., Chikwambi, Z., Kuona, P., & Masimirembwa, C. (2023). Pharmacogenetics of pain management in Zimbabwean patients with sickle cell disease. Pharmacogenomics, (0).	en_US
dc.identifier.issn	ISSN 1462-2416
dc.identifier.uri	https://ir.cut.ac.zw:8080/xmlui/handle/123456789/490
dc.description.abstract	: Failure to effectively control pain remains a challenge in sickle cell disease (SCD) patients. This cross-sectional study in 106 Zimbabwean SCD patients demonstrated the role of UGT2B7 polymorphism in SCD patient pain management. #AiBST #pharmacogenetics #sickle cell disease	en_US
dc.language.iso	en	en_US
dc.publisher	ResearchGate	en_US
dc.subject	codeine	en_US
dc.subject	CYP2D6	en_US
dc.subject	genetic variation	en_US
dc.subject	morphine	en_US
dc.subject	opioids	en_US
dc.subject	pharmacogenomics	en_US
dc.subject	tramadol	en_US
dc.subject	UGT2B7	en_US
dc.title	Pharmacogenetics of pain management in Zimbabwean patients with sickle cell disease	en_US
dc.type	Article	en_US